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Abstract.  mAbs specific for protein components of 
the surface membrane of rabbit skeletal muscle have 
been used as markers in the isolation and characteriza- 
tion of skeletal muscle sarcolemma membranes. 
Highly purified sarcolemma membranes from rabbit 
skeletal muscle were isolated from a crude surface 
membrane preparation by wheat germ agglutination. 
Immunoblot analysis of subcellular fractions from 
skeletal muscle revealed that dystrophin and its as- 
sociated glycoproteins of 156 and 50 kD are greatly 
enriched in purified sarcolemma vesicles. The purified 
sarcolemma was also enriched in novel sarcolemma 
markers (SL45, SL/TS230) and Na+/K+-ATPase, 
whereas t-tubule markers (oft and or2 subunits of di- 
hydropyridine receptor,  TS28) and sarcoplasmic reticu- 
lurn markers (Ca2+-ATPase,  ryanodine receptor) were 
greatly diminished  in this preparation. 
Analysis of isolated sarcolemma by SDS-PAGE and 
densitometric scanning demonstrated that dystrophin 
made up 2 % of the total protein in the rabbit sar- 
colemma preparation.  Therefore,  our results demon- 
strate that although dystrophin is a minor muscle pro- 
tein it is a major constituent of the sarcolemma 
membrane in skeletal muscle. Thus the absence of 
dystrophin in Duchenne muscular dystrophy may re- 
sult in a major disruption of the cytoskeletal network 
underlying the sarcolemma in dystrophic muscle. 
YSTROPHIN, the protein product of the human Du- 
chenne muscular dystrophy gene (DMD) t (18), is 
localized to the sarcolemma membrane in normal 
skeletal muscle (2, 5, 49, 51) but is absent from skeletal mus- 
cle of DMD humans (2, 18, 19), mdx mice (18, 49) and xmd 
dogs (13). Dystrophin  represents  ~0.002 % of the total mus- 
cle protein (18) and its predicted primary structure suggests 
that it shares many features with membrane cytoskeletal pro- 
teins such as ot-actinin and spectrin (29). Dystrophin can be 
isolated from skeletal muscle membranes using WGA chro- 
matography  because  of its  tight  association  with  WGA- 
binding glycoproteins (7). Recently, we have shown that dys- 
trophin exists in a large oligomeric complex which contains 
four glycoproteins of apparent  Mr 156,000, 50,000, 43,000 
and 35,000 and a protein triplet at 59,000 (15). One of the 
glycoproteins  in the dystrophin-glycoprotein complex has 
been found to be greatly reduced in muscle from mdx mice 
and  DMD patients.  Therefore,  the absence of dystrophin 
leads to the loss of at least one component of the dystrophin- 
glycoprotein complex and this could initiate  the molecular 
pathogenesis of muscular dystrophy (15). 
Since it is apparent that the degenerative processes leading 
to DMD are associated with the surface membrane of skele- 
1. Abbreviations used in this paper: DMD, Duchenne muscular dystrophy; 
DYS, dystrophin; NAG,  N-acetyl-o-glueosamine; SL,  sarcolemma; "IS, 
transverse tubule system. 
tal muscle, it is important to be able to study the structure 
of isolated sarcolemma to identify the normal protein com- 
position of the sarcolemma membrane from skeletal muscle 
and  to determine the relative  abundance of dystrophin  to 
other sarcolemma proteins.  For the biochemical character- 
ization  of surface membrane  components,  which  are  in- 
volved in  the pathology of muscle diseases,  sarcolemma 
vesicles have to be prepared in a sufficient yield with a high 
degree of purity. A variety of procedures have been used to 
isolate skeletal muscle fractions enriched in sarcolemma, 
most involving  density gradient centrifugation  (3,  32, 40, 
41). However, due to the low abundance of sarcolemma to 
other membranes in skeletal muscle, in particular sarcoplas- 
mic reticulum, density gradient centrifugation  has not pro- 
duced a sarcolemma membrane preparation that gives a sub- 
stantially  different  SDS-PAGE  profile  in  comparison  to 
purified  sarcoplasmic reticulum. 
Recently, Charuk et al. (12) successfully used wheat germ 
agglutination procedure after density gradient centrifugation 
for the subfractionation  of cardiac sarcolemma.  WGA is a 
homodimer  that  cross-links  terminally  linked  N-acetyl-D- 
glucosamine and/or sialic acid (4), thus, lectin agglutination 
should aggregate specifically sealed right-side-out  sarcolem- 
ma vesicles because the carbohydrate chains  of membrane 
glycoproteins  are extracellular  (12). 
Here we report the isolation of highly purified sarcolemma 
vesicles  from rabbit skeletal muscle using  sucrose density 
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Our approach was to characterize  the isolated  sarcolemma 
vesicles by immunological  analysis using mAbs. Novel pro- 
teins are introduced as specific markers for the sarcolemma, 
the  sarcolemma and transverse  tubule membrane,  or the 
transverse tubule system of rabbit skeletal muscle, using im- 
munoblot and immunofluorescence  localization  techniques. 
Our findings demonstrate that the tightly associated dys- 
trophin-glycoprotein complex (15) is restricted to the cell 
periphery of skeletal  muscle cells and that dystrophin  is a 
major protein constituent  of the rabbit sarcolemma mem- 
brane, i.e.,  ,,02% of the total skeletal  muscle sarcolemma 
protein. 
Materials and Methods 
Isolation of  Rabbit Skeletal Muscle Membranes 
New Zealand white rabbits (5 lb) were euthanized by ketamine injection, 
and all subsequent steps were carried out at 0-4°C. Approximately  450 g 
of back and hind leg white skeletal muscles was excised, ground in a meat 
grinder and weighed. Tissue was homogenized in a Waxing blender 0Varing 
Products Div., New Hartford,  CT) for three times 30 s in 7.5 vol of buffer 
A (20 mM sodium pyrophosphate,  20 mM sodium phosphate monohydrate, 
1 mM MgC12, 0.303 M sucrose,  0.5 mM EDTA, pH 7.0) in the presence 
of protease inhibitors: aprotinin (76.8 nM), leupeptin  (1.1 uM), pepstatin 
A (0.7 ttM), benzamidine (0.83 raM), iodoacetamide (1 raM), and PMSF 
(0.23 mM). All other buffers contained the last three protease inhibitors at 
the above concentration. The homogenate was centrifuged  in a JA-10 rotor 
(Beckman Instruments, Fullerton, CA) for 15 rain at 14,000 g and the su- 
peruatant  filtered  through six  layers  of cheesecloth.  The pellets  were 
resuspended  in buffer A (70% of the original volume) and rehomogenized 
and centrifuged as described before. The supernatants were combined and 
centrifuged in a JA-14 rotor (Beckman Instruments) for 30 rain at 30,000 g 
and the resulting supematant and microsomal pellets were used to isolate 
light microsomes and microsomes, respectively.  Microsomai pellets were 
resuspended  and incubated for 30 min in 400 ml of 0.6 M KC1, 0.303  M 
sucrose, 50 mM Tris-HC1, pH 7.4 and subsequently centrifuged in a Beck- 
man 45Ti rotor (Beckman Instruments) for 30 rain at 142,000 g to obtain 
KCl-washed  microsomes.  The final  microsomal preparation was  resus- 
pended in buffer B (0.303 M sucrose,  20 mM Tris-maleate,  pH 7.0). 
Light microsomes were obtained from the supernatant of the JA-14 rotor 
spin, after adding solid KC1 to a final concentration of 0.6 M to the suspen- 
sion, by centrifuging it in a 45Ti rotor for 35 rain at 142,000 g. The pellets 
were resuspended in 400 mi of buffe~"  B and again treated with KC1 and cen- 
trifuged as described above.  The final pellets  of light microsomes were 
resuspended  in 30 ml of buffer B containing 0.6 M KC1 and 5-ml aliquots 
were  loaded onto 35 ml of 0.878 M  sucrose,  0.6 M  KCI, 20 mM Tris- 
maieate,  pH 7.0 in ultraclear,centrifuge tubes and centrifuged  in an SW28 
swinging bucket rotor (Beckman Instruments) at 112,000 g for 17 h. The 
crude surface membrane fraction at the 0.303 M/0.878 M sucrose interface 
and the pellets were collected, diluted with 0.6 M KCI, 20 mM "fi'is-maleate, 
pH 7.0 and centrifuged  in a 45Ti rotor for 30 rain at 142,000 g. All mem- 
brane preparations were  resuspended in buffer  B  and stored frozen  at 
-135°C.  Protein concentration was determined as described (35) using 
BSA as standard. Approximately  30 mg of crude surface  membrane was 
typically  obtained from 450 g of skeletal  muscle. 
Triads and t-system vesicles were isolated according to Sharp et al. (43) 
and Rosemblatt et al. (36), respectively. Light sarcoplasmic reticuhim veil- 
cles were prepared as described previously  (6). 
Isolation of Purified Sarcolemma by Wheat 
Germ Agglutination 
To further purify the crude surface membrane preparation, vesicles were 
treated with WGA in principle as described by Charuk et al. (12). Crude 
surface membrane vesicles were resuspended at a protein concentration of 
1 mg/mi in buffer C (50 mM sodium phosphate, pH 7.4, 0.160 M NaCl) and 
gently mixed with an equal volume of I mg/ml wheat germ lectin (Sigma 
Chemical Co., St. Louis, MO) in buffer C. Total volume of this mixture 
was 60 ml and after a 10-rain incubation on ice the solution was pelleted 
in a centrifuge  (Eppendorf model 5402) for 90 s at 14,000 g. The lectin- 
agglutinated vesicles were resuspended in buffer D (20 mM Tris-HC1, pH 
7.4, 0.303 M sucrose) and centrifuged as described above. This procedure 
was repeated and the resuspended pellets were then deagglutinated by incu- 
bation for 20 rain in 18 ml of 0.2 M N-acetyl-D-giucosamine  in buffer D. 
The deagglutinated  suspension was centrifuged in an Eppendorf centrifuge 
for 90 s at 14,000 g and the supernatant pelleted in a TLI00.3 rotor (Beck- 
man Instruments) for 20 rain at 150,000 g, resuspended in buffer D and cen- 
trifuged for 20 rain at 150,000 g  as described above.  Subsequently  the 
pellets were resuspended  in 9 mi of buffer C and treated for a second time 
with lectin and finally deagglutinated as described above. The final prepara- 
tion was  designated purified sarcolemma.  The nonagglutinated  vesicles 
were centrifuged  for 20 min at 150,000 g and the pellets consisted mostly 
of sarcoplasmic  reticulum and transverse tubule vesicles. Starting with 30 
mg crude surface membranes, the yield of purified sarcolemma and nonag- 
glutinated vesicles  was ,~4 and 18 nag, respectively. 
Monoclonal and Polyclonal  Antibodies 
mAbs were prepared against antigens associated with skeletal  muscle sar- 
colemma, sarcolemma and transverse tubules, or transverse tubules and 
used for immunoblotting and immunofluorescence  analysis. Production and 
characterization of mAbs against membrane marker proteins was carried 
out by immunizing mice with various  rabbit skeletal  muscle membrane 
preparations as described previously (9, 25, 26). An immunodot assay was 
used for the initial screening of the hybridoma supernatants,  followed by 
immun0hlot and immunofluorescence  analysis to further characterize the 
specificity  of the new mAbs. 
New mAbs XVB9 and IXC12 are directed against a 45-kD sarcolemma 
protein and a 230-kD sareolemma/transverse tubule protein, respectively. 
For the characterization of previously  established mAbs used in this 
study see the following publications: mAbs lID8 and IIHI 1 against the slow- 
and fast-twitch  Ca2+-ATPase of sareoplasmic  reticulum (25),  mAbs IIF7 
and IIID5 against the ¢xl-subunit of the 1,4-dihydropyridine  receptor (26), 
mAb IXEll2 against  a  28-kD transverse tubule protein (27),  mAb XA7 
against the ryanodine receptor (9, 22), [nAb IVD31 against the 50-kD gly- 
coprotein of sarcolemma (27), mAb VIA41 against the 156 kDa giycopro- 
tein of sareolenuna (15), mAb XIXC2 against dystrophin (15), mAb McB2 
against the ~2-subunit of the Na+/K+-ATPase (Dr.  K. J. Sweadner,  Dept. 
of Cellular and Molecular Physiology,  Harvard Medical  School, Boston, 
MA [48]). mAb MF20 against myosin was obtained from the Developmen- 
tal Studies Hybridoma Bank at the University of Iowa and mAb 5C5 against 
actin from Sigma Chemical Co. mAbs against marker proteins used in this 
study are summarized in Table I. 
Polyclonal antisera against the ot2-subunit of the dihydropyridine  recep- 
tor (42)  and against the COOH-terminal decapeptide  of dystrophin (15) 
were  raised  in  guinea  pig  and  rabbit,  respectively.  The  decapeptide 
representing the  COOH-terminal of human skeletal  muscle dystrophin 
(Pro-Gly-Lys-Pro-Met-Arg-Glu-Asp-Thr-Met)  (29) was chemically synthe- 
sized on a peptide synthesizer (model 430A; Applied Biosystems, Inc., Fos- 
ter City,  CA)  by the Alberta Peptide  Institute,  University of Alberta, 
Canada, using methods previously described (45). The COOH-terminal se- 
quence of dystrophin is almost completely  different  from the COOH- 
terminal sequence of a dystrophin-related protein (31). The photoprobe, 
p-benzoylbenzoic acid, was coupled directly to the protected peptide resin 
during synthesis and the resulting photoprobe peptide was purified using 
reverse-phase HPLC. The purified peptide was photochemicelly coupled to 
BSA as described (34) and the peptide to protein ratio was  17:1. 
Gel Electrophoresis and Densitometric Analysis 
SDS-PAGE was performed according to Laeramli (30) in 3-12 % polyacryl- 
amide gels. Protein bands were visualized by Coomassie brilliant  blue stain- 
ing and also analyzed by Stains-all  staining for Ca2+-binding proteins (8). 
Densitometric scanning of Coomassie brilliant blue-stained SDS-PAGE 
gels was carried out on a computing densitometer (model 300A; Molecular 
Dynamics)  and also on a densitometer (model  GS 300; Hcefer Scientific 
Instruments, San Francisco,  CA). 
lmmunoblotting and Lectin Staining 
Proteins separated by SDS-PAGE were transferred to nitrocellulose  mem- 
branes by the method of Towbin et al. (46).  Prestained molecular weight 
standards were from Bethesda Research Laboratories (Gaithersburg,  MD) 
and the apparent molecular masses were as follows: myosin, 224 kD; phos- 
phorylase b, 109 kD; albumin, 72 kD; ovalbomin, 46 kD; and carbonic an- 
hydrase, 29 kD. Nitrocellulose  transfers were blocked in Blotto (50 mM so- 
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Immunoblotting 
(isolated membranes) 
Specificity  M,  Ab  LSR  TR  TS  SL 
Immunofluoreseence 
(in situ) 
SR  TS  SL  Reference 
kD 
Sarcolemma 
Dystrophin  427  XIXC2  -  -  +  + + + 
SL 156  156  VIA4~  -  -  +  + + + 
SL 50  50  IVD3~  -  -  +  + + + 
SL 45  45  XVB9  -  -  +  + + + 
Transverse tubules and sarcolemma 
SL/TS 230  230  IXC12  -  +  +  + 
Na÷/K+-ATPase  112  McB2  -  +  +  + 
Transverse tubules 
DHPR subunits 
a~  170  IIID5  -  +  ++  - 
ex~  170  IIF7  -  +  + +  - 
or2  175  GP5SA  -  +  ++  - 
B  52  VD2~  -  +  ++  - 
TS28  28  IXEll2  -  +  ++  - 
Junctional sarcoplasmic reticulum 
Ryanodine receptor  565  XA7  -  + +  -  - 
Free sarcoplasmic reticulum 
Fast Ca2+-ATPase  110  IIHI 1  + + +  + +  + +  + 
Slow CaZ+-ATPase  110  IID8  +++  ++  ++  + 
+  7,  15 
+  15 
+  15,  27 
+  * 
+  +  * 
(ND)  48 
+  --  -'  26 
+  -  26  i" 
(ND)  43 
+  -  26 
+  -  27 
(ND)  9,  22 
++  --  -  25 
++  -  --  25 
* This study. 
Abbreviations: DHPR, dihydropyridine receptor; LSR, light sarcoplasmic reticulum; TR0 triads; "IS, transverse tubule system; SL, sarcolemma. 
dium phosphate,  pH 7.4, 150 mM sodium chloride,  5% nonfat dry milk) 
and subsequently  incubated overnight with primary  antibody (hybridoma 
supernatant  or 1:1,000 dilution of a concentrated  antibody).  Immunoblots 
were then washed with Blotto and incubated for I h with peroxidase-conju- 
gated  secondary  antibody  (Boehringer-Mannheim  Bioehemieals,  Indi- 
anapolis, IN) at a dilution of 1:1,000. After washing the nitrocellulose blots 
with Blotto they were developed in 20 mM Tris-Cl, pH 7.5, 200 mM NaCI 
using 4-chloro-l-naphthol  as substrate  (27). 
Immunoblots were also stained with t25I-WGA agglutinin (ICN Radio- 
chemicals,  Irvine,  CA) in the presence  or absence of 0.3 M N-acetyl-o- 
glucosamine  as described  previously  (7). 
lmmunofluorescence Microscopy 
Immunofluorescence staining of transverse and longitudinal cryosections (8 
~m)  from rabbit  skeletal  muscle (gastrocnemius)  was carried out as de- 
scribed previously  (15). Cryosections  were preincubated  for 20 min with 
5 % normal goat antiserum in PBS (50 mM sodium phosphate, pH 7.4, 0.9 % 
NaC1), "followed  by a 1-h incubation at 37°C with the primary antibody (hy- 
bridoma supernatants or 1:1,000 dilution of a concentrated antibody). After 
washing in PBS the sections were further incubated for 30 rain at 37°C in 
PBS  with a  1:50 dilution  of affinity-purified FITC-iabeled  goat  F(at02 
anti-mouse IgG (Boehringer-Mannheim)  and subsequently examined in a 
Zeiss Axioplan fluorescence microscope. 
Immunofluorescence labeling of biopsy samples of normal control and 
patients with Duchetme muscular dystrophy (obtained from the Department 
of Neuropathology, University of Iowa) were carried out with the cryosee- 
tions of the control and the dystrophic muscle sample placed on the same 
microscope slide and the samples were therefore treated in an identical man- 
ner during all incubation and washing steps. 
Histochemical Staining 
Serial transverse cryosections of unfixed rabbit gastrocnemius muscle were 
stained for myosin ATPase after alkaline preincubations  (pH  10.4) as de- 
scribed by Guth and Samaha (17). This method specifically labels the myo- 
sin ATPase of only fast-twitch skeletal muscle fibers. 
Results 
mAbs to Skeletal Muscle Membrane Proteins 
mAbs against antigens that are closely associated with differ- 
ent  muscle  membrane  systems  were  used  to  characterize 
fractions  in  the  purification  of sarcolemma  vesicles  from 
rabbit  skeletal muscle.  After  initial  screening  with  im- 
munodot assays, positive cell cultures were assayed for anti- 
bodies able to recognize antigens in skeletal muscle mem- 
brane  preparations  by  immunoblotting.  New mAbs  XVB9 
and  IXC12  label protein  bands  in  KCl-washed  microsomes 
of 45  and  230  kD,  respectively  (see  Fig.  7).  Immunoblot 
analysis  of the  purified  dystrophin-glycoprotein  complex 
(15) revealed that both proteins are not integral components 
of this complex (results not shown),  mAbs that exhibited a 
strong labeling in immunoblotting, were tested using indirect 
immunofluorescence  microscopy  on  skeletal  muscle  cryo- 
sections.  There are principally three different categories of 
surface membrane antigens, those which are restricted to the 
sarcolemma,  or  the  transverse  tubules,  or  those  that  are 
localized in both  membrane  systems.  While the new mAb 
XVB9 is directed against a  45-kD protein that is restricted 
to  the  sarcolemma,  the  new  mAb  IXC12  against  230-kD 
protein is found in both the sarcolemma and the transverse 
tubule (Fig.  1). 
Other mAbs' to skeletal muscle membrane proteins  were 
previously characterized  and are  specific for the slow- and 
fast-twitch Ca2+-ATPase of sarcoplasmic reticulum (25), the 
dihydropyridine receptor and TS28 protein of transverse tu- 
bules (26, 27), the ryanodine receptor of triads (9, 22), com- 
Ohlendieck et al. Dystrophin-Glycoprotein Complex in Sarcolemma  137 Figure 1. Immunofluorescence  labeling of rabbit skeletal muscle with novel mAbs against SL45 and SL/TS 230. Cryosections from rabbit 
gastrocnemius muscle were prepared and labeled by the indirect immunofluorescence  technique as described in Materials and Methods. 
Transverse (a and b) and longitudinal (c and d) cryosections from rabbit skeletal muscle, were labeled with mAb XVB9 against SL45 
(a and c), mAb IXC12 against SL/TS 230 (b and d). Immunofluorescence  labeling for SL45 was restricted to the sarcolemma, whereas 
mAb IXC12 to SL/TS 230 exhibited in addition to labeling of the cell periphery also an internal polygonal staining pattern in transverse 
sections and specific labeling of the A-I junction region in longitudinal cryosections. Bar, 5/~m. 
ponents of the dystrophin-glycoprotein  complex (15) and the 
Na÷/K+-ATPase (48). Thus, these mAbs could then be used 
for further immunoblot staining to establish the purity and 
distribution pattern of specific antigens in the various skele- 
tal muscle membrane systems. Table I summarizes the mAbs 
against marker proteins used in this investigation. 
Immunofluorescence Localization of Surface 
Membrane Components 
In immunofluorescence microscopy mAb XVB9 against a 
45-kD protein exclusively labeled the cell periphery in trans- 
verse and longitudinal cryosections of rabbit skeletal muscle 
(Fig.  1,  a  and  c).  Staining was absent from the  interior 
regions of skeletal muscle fibers, suggesting that the 45-kD 
protein is only associated with the sarcolemma. Examination 
of Fig.  1 b reveals that the immunofluorescence labeling of 
mAb IXC12 against a 230-kD protein is not confined to the 
sarcolemma region, but also extends to a polygonal internal 
staining pattern. These results are confirmed by longitudinal 
cryosections, which localize the 230-kD protein to the A-I 
junction and sarcolemma region (Fig.  1 d). 
The localization pattern of the two new mAbs was com- 
pared with established marker proteins of rabbit  skeletal 
muscle.  The  cell periphery  was  exclusively stained  with 
mAbs XVB9 against the 45-kD protein, IVD3t against the 
dystrophin-associated  50-kD glycoprotein and XIXC2 against 
dystrophin (Fig. 2), demonstrating the specific association of 
these antigens with the muscle fiber plasma membrane or the 
intracellular cytoskeleton subjacent to the plasma membrane. 
All three antigens exhibited a uniform distribution through- 
out the sarcolemma in transversely and longitudinally cut 
cryosections (Fig. 2, a-f). The absence of any internal im- 
munofluorescence staining establishes these antigens as con- 
venient sarcolernma markers, mAb VIA4t against the dys- 
trophin-associated 156-kD  glycoprotein also labels the cell 
periphery, but only very weakly (15). The antibody recog- 
The Journal of Cell Biology, Volume 112, 1991  138 Figure 2. Distribution of SL45, SL50, and dystrophin in rabbit skeletal muscle. Immunofluorescence labeling of transverse (a, c, and e) 
and longitudinal (b, d, and f) cryos~-'tions from rabbit skeletal muscle, stained with mAb XVB9 against SL45 (a and b) mAb IVD31 
against SL50 (c and d) and mAb XIXC2 against dystrophin (e and f). All three mAbs specifically labeled the cell periphery, whereas 
specific staining was not observed in internal regions of muscle fibers. Bar, 5/~m. 
nizes the denatured protein in a much stronger manner and 
shows strong labeling of  the 156-kD glycoprotein  band in im- 
munoblots (see Figs.  7, 9,  and 10). 
Fig. 3 compares the immunofluorescence labeling of mAb 
IXC12  against the 230-kD protein with that of mAb IIID5 
against  the  ~Xl-SUbtmit of the  dihydropyridine receptor,  a 
transverse tubule marker (26). Both proteins exhibit a polyg- 
onal staining pattern of the cell interior (Fig.  3, a  and c), 
Ohlendieck et al. Dystrophin-Glycoprotein  Complex in Sarcolemma  139 Figure 3.  Distribution of SL/TS 230 and dihydropyridine  receptor in rabbit skeletal muscle. Immunofluorescence  labeling of transverse 
(a and c) and longitudinal (b and d) cryosections from rabbit skeletal muscle, stained with mAb IXCI2 against SL/TS 230 (a and b) and 
mAb IIID5 against the ~-subunit of dihydropyridine  receptor (DHPR) (c and d). Both mAbs exhibited in transverse cryosections a poly- 
clonal staining pattern throughout the cytoplasm of the myofibers  and labeled the A-I junction region in longitudinal sections. In addition, 
mAb IXC12 also specifically labeled the cell periphery. Bar, 5/~m. 
characteristic for their localization in transverse tubules. On 
the other hand, transverse and longitudinal cryosections of 
Fig. 3, a and b demonstrate that the staining pattern of mAb 
IXC12 extends to  the  sarcolemma region,  whereas  mAb 
IIID5 exclusively labels internal regions of the muscle fibers 
(Fig.  3,  c  and d). 
Since muscles contain various fiber types, it is important 
to be aware  of the fiber type specificity of mAbs used as 
markers for sarcolemma isolation. We have investigated the 
fiber type distribution of the different marker proteins used 
in  this  study using  serial  transverse  sections  of gastroc- 
nernius muscle stained with each mAb.  Fig.  4  a  demon- 
strates  histochemically the  distribution  of type  I  (slow- 
twitch) and type II (fast-twitch) fibers in serial transverse 
cryosections. Alkaline-stable myosin ATPase is a  specific 
histochemical marker for fast-twitch type II fibers. The jm- 
munofiuorescence staining pattern of mAb IIH11 and IID8 
against the fast- and slow-twitch Ca2+-ATPase, respectively, 
confirms the distribution pattern of the alkaline stable myo- 
sin ATPase (Fig. 4, b and d). mAb HID5 to the dihydropyri- 
dine receptor strongly labeled fiber type II and less inten- 
sively fiber type I  (Fig.  4  c),  which reflects  the different 
abundance of transverse  tubules  in  fast and  slow muscle 
fibers (14). After establishing the fiber type distribution of 
the serial transverse sections used in this investigation, the 
immunofiuorescence staining pattern of novel marker pro- 
teins and components of the dystrophin glycoprotein com- 
plex were analyzed. All three mAbs  against sarcolemma 
markers,  XVBg,  XIXC2,  and IVD3,,  illustrated an equal 
distribution between fast and slow fibers (Fig. 4, f-h).  ;l'here- 
fore, the components of the dystrophin-glycoprotein com- 
plex seem to be equally distributed between fibers of type I 
and II. mAb IXC12, which specifically stains both the cell 
periphery  and  the  cell  interior,  shows  an  identical  im- 
munofluorescence intensity of the sarcolemma in both fiber 
types (Fig. 4  e).  On the other hand, slow fibers exhibited 
much less internal polygonal labeling than fast fibers. This 
polygonal staining pattern is similar to that of IIIDS, which 
is consistent with the fact that the 230-kD protein is closely 
associated with the transverse tubules and therefore more 
abundant in the interior of fast fibers than slow fibers. 
Recent work in the field of DMD research has indicated 
the existence of dystrophin-related proteins  that have se- 
quence  homology with dystrophin but are  encoded by a 
different gene and therefore are likely to be present in DMD 
muscle (20, 23, 31). To be certain that we are identifying  dys- 
trophin and not dystrophin-related proteins, it is important 
to confirm the specificity of the antibodies used in our study 
by immunofluorescence  experiments with normal and DMD 
muscle.  This ensures that these antibodies are  not cross- 
reactive with dystrophin-related proteins, spectrin or alpha- 
actinin (21, 33). Dystrophin-related proteins are most likely 
not affected in dystrophic muscle and would therefore be de- 
tectable in DMD muscle biopsies with cross-reactive anti- 
bodies. To establish the specificity of mAb XIXC2 against 
dystrophin and the  polyclonal rabbit  antisera  against the 
COOH-terminal  decapeptide  of  dystrophin,  cryosections 
from normal and dystrophic skeletal muscle were tested with 
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of  normal human muscle cells is strongly labeled by both an- 
tibodies  against  dystrophin,  whereas  no  immunofluores- 
cence  staining is  observed  in biopsy  samples  from four 
different DMD patients. In immunoblot analysis the poly- 
clonal rabbit antisera against the COOH-terminal deeapep- 
tide, which strongly reacts with normal mouse muscle mem- 
branes, exhibited no staining ofmdx muscle membranes (15) 
and mAb XIXC2 strongly labeled a 427-kD protein in nor- 
mal human muscle extracts but not in biopsy samples from 
DMD patients (results not shown). These results establish 
mAb XIXC2 and the polyclonal antisera against the COOH- 
terminal decapeptide of dystrophin as excellent probes for 
dystrophin. 
Isolation of Crude Surface Membranes  from 
Rabbit Skeletal Muscle 
The initial purification steps of isolating skeletal muscle sar- 
colemma  involved  the  preparation  of  KCl-washed  light 
microsomes and crude surface membranes.  These proce- 
dures are outlined in the flow chart of Fig. 6. Sucrose step 
gradient centrifugation produced a fraction enriched in sur- 
face membrane components, as illustrated by the irnmuno- 
blots of Fig. 7. The relative amounts of surface membrane 
markers (SIA5, SL/TS 230) and components of the dystro- 
phin-glycoprotein complex (dystrophin, SL156, SL50) is in- 
creased in crude surface membrane vesicles, as compared 
with KCl-washed and light microsomes. These results and 
the relatively high yield of 30 mg crude surface membrane 
vesicles obtained from 450 g of starting material establish 
the crude surface membrane fraction from rabbit skeletal 
muscle as a convenient source of sarcolerama vesicles for 
further purification steps. 
Wheat Germ Agglutination of  Sarcolemma Vesicles 
Purified sarcolemma vesicles were prepared by a wheat germ 
agglutination procedure, as outlined in the flow chart of Fig. 
8.  Aggregation of sarcolemma vesicles  by  WGA  should 
selectively isolate sealed right-side out vesicles, because of 
the extracellular position of  the carbohydrate chains of mem- 
brane glycoproteins. Fig. 9 illustrates the protein composi- 
tion of the sarcolemma vesicle fraction and the nonaggluti- 
nated vesicles, as analyzed by SDS-PAGE,  lectin staining, 
and imrnunoblotting. The Coomassie blue-stained protein 
band pattern of the different fractions revealed that the pro- 
tein  composition  of the  sarcolemma  membrane  vesicles 
differed from the crude surface membranes and the nonag- 
glutinated vesicles, especially with respect to the greatly di- 
minished protein band of apparent molecular mass 110 kD 
and a more intense protein band pattern in the range between 
20 and 60 kD (Fig. 9, Coomassie). Staining of an identical 
gel with the cationic carbocyanine dye "Stains-all" showed 
a greatly diminished staining intensity of Ca~+-binding pro- 
tein bands of 63 and 110 kD in the sarcolemma membrane 
fraction, as compared with the starting material and the 
nonagglutinated  vesicles (results not shown). The red stained 
band of 110 kD and the blue stained band of 63 kD cor- 
respond to the Ca2+-ATPase and calsequestrin, both compo- 
nents of the sarcoplasmic reticulum,  which appear  to be 
greatly  reduced  in  the  sarcolemma  membrane  fraction. 
Labeling with t25I-WGA  illustrates the enrichment of WGA- 
positive glycoproteins in  the  sarcolemma vesicle fraction 
compared with the starting material of crude surface mem- 
branes (Fig. 9, WGA). Besides the several glycoproteins in the 
range between 80 and 170 kD, two dominating WGA-positive 
glycoproteins of apparent 30 and 460 kD appear to be highly 
enriched in the sarcolemma vesicle fraction. On the other 
hand, the non-agglutinated vesicle fraction contained only 
one major WGA-binding protein of apparent 150 kD. Identi- 
cal  control blots  were  not labeled  with  ~zsI-WGA in  the 
presence of 0.3  M N-acetyl-v-glucosamine which demon- 
strates the specificity of  the WGA binding pattern (results not 
shown). 
Transverse tubule markers, the ot2-subunit of the dihydro- 
pyridine receptor and TS28 protein, appear to be restricted 
to the nonagglutinated vesicle fraction (Fig. 9,  otz DHPR, 
TS28). These results indicate that the crude surface mem- 
brane preparation contains transverse tubule vesicles with a 
predominant inside-out orientation, which are not aggluti- 
nated by WGA and therefore stay in the supernatant. As ex- 
pected on the basis of these findings, mAb IXCI: against 
the SLITS230 stains both, the nonagglutinated vesicles and 
the sarcolemma membrane fraction (Fig. 9, SL/TS230). The 
230-kD protein seems to be associated with the predomi- 
nantly right-side-out sarcolemma vesicles and the inside-out 
transverse tubule vesicles, as already illustrated by the polyg- 
onal immunofluorescence pattern of the cell interior and as 
well staining of the cell periphery (Figs. 1 and 3). Labeling 
with mAb MoB2 against the Na+/K+-ATPase revealed that 
this antigen seems to be also associated with both, the nonag- 
glutinated vesicles and the sarcolemma membrane vesicle 
fraction (Fig. 9, Na/K-ATPase). 
mAb XVB9, which appears in immunofluorescence mi- 
croscopy to be a very good sarcolemma marker (Figs. 1 and 
2), labels, in agreement with this result, almost exclusively 
the sarcolemma vesicle fraction (Fig. 9, SL45).  Fig. 9 also 
illustrates that dystrophin and its associated glycoproteins of 
156 and 50 kD are almost uniquely associated with the sar- 
colemma fraction using mAbs XIXC2,  VIA4~ and IVD3~ 
as markers. 
SubceUular Localization of  Dystrophin Glycoprotein 
Complex in Isolated Sarcolemma Vesicles 
mAbs against previously established sarcolemma and trans- 
verse tubule markers and the two novel markers that were in- 
troduced in this study were used to characterize the degree 
of  purity of subcellular fractions from rabbit skeletal muscle. 
Membrane vesicles from light sarcoplasmic reticulum, triads 
and transverse tubules were isolated by established proce- 
dures and sarcolemma vesicles were isolated by wheat germ 
agglutination as described in Materials and Methods. Mem- 
brane fractions were carefully prepared in the presence of a 
protease inhibitor cocktail and separated on 3-12%  SDS- 
PAGE gel to characterize the range of low and high apparent 
molecular mass marker proteins of interest in immunoblot- 
ting experiments. 
The Ca2+-ATPase of apparent  110  kD is a  well-defined 
marker of  the sarcoplasmic reticulum and mAb IIH11 against 
this antigen strongly labeled sarcoplasmic reticulum, triads, 
and transverse tubules, but only weakly saxcolemma vesicles 
(Fig.  10,  Ca-ATPase).  This Ca2+-ATPase seems to be the 
most frequent contaminant of skeletal muscle membrane 
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Shown are transverse cryosections of normal human skeletal muscle (a and b) and dystrophic skeletal muscle from a DMD patient (c and 
d) labeled with mAb XIXC2 against dystrophin (a and c) and polyclonal rabbit antisera against the COOH-terminal decapeptide of dystro- 
phin (b and d). Both antibodies localize dystrophin to the cell periphery of normal human muscle cells and exhibit no labeling of human 
dystrophic muscle. Bar, 5 #m. 
preparations, possibly due to its high abundance. The WGA- 
agglutinated sarcolemma fraction exhibits,  compared with 
transverse tubule preparations, only small amounts of con- 
taminating components derived from the sarcoplasmic retic- 
ulum. To quantitate the amount of contaminating sarcoplas- 
mic  reticulum  in  the  sarcolemma fraction,  we  compared 
immunoblot staining intensity of various amounts of sarco- 
plasmic reticulum and triads with sarcolemma. Densitomet- 
ric scanning of autoradiographs of lz~I-secondary antibody 
labeled  anti-Ca2÷-ATPase and  anti-caisequestrin  indicated 
that the content of sarcoplasmic reticulum in the sarcolemma 
enriched fraction was '~8 %  (results not shown). 
Staining with mAh XA7 revealed that the ryanodine recep- 
tor Ca2+-release channel  is restricted to the triad  fraction 
Figure 4.  Distribution of skeletal muscle membrane proteins in type I (slow) and type II (fast) myofiber of rabbit gastrocnemius.  Serial 
transverse cryosections of rabbit gastrocnemius were histochemicaUy stained for alkaline-stable myosin ATPase, a marker for type II (fast) 
myofibers (a) and immunofluorescently labeled with mAb HHll against fast Ca2+-ATPase  (b), mAb hiD5 against dihydropyridine recep- 
tor (DHPR) (c), mAb lID8 against slow Ca  2+ ATPase (d), mAb IXC12 against SL/TS 230 (e), mAb XVB9 against SIA5 (f), mAb XIXC2 
against dystrophin (g), and mAb IVD3] against SL50 (h). The fibre type distribution  of slow and fast Ca2+-ATPase  corresponds  to the 
histocbemical staining pattern of alkaline-stable myosin ATPase. The internal staining pattern of mAb HID5 and IXClz were both more 
intense in fast than in slow myofibers, which agrees with the higher abundance of transverse tubules in fast fibers compared with slow 
fibers. The intensity of labeling of the cell periphery of type I (slow) fibers with mAbs IXCI2, XVB9, XIXC2 and IVD3t was indistin- 
guishable from that of type n  (fast) fibers. Bar, 20 ~m. 
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Figure 6. Flow chart of procedure to isolate crude surface mem- 
brane vesicles. KCl-washed  light microsomes were prepared from 
rabbit skeletal muscle homogenate by differential centfifugation 
and subsequently  crude surface membrane vesicles isolated by su- 
crose step gradient centrifugation. Next to the isolated fractions is 
the lane number in parentheses that will appear in the immunoblot 
analysis of Fig. 7. 
(Fig.  10,  RyR).  mAb  MD5  to  the  o~rsubunit  of the  di- 
hydropyridine receptor labeled strongly the transverse tu- 
bule fraction and also triads, but not the purified sarcolemma 
vesicles, indicating a  good removal of t-system from sar- 
colemma in the WGA agglutination  procedure. Furthermore, 
purified sarcolemma was stained with sarcolemma marker 
mAb XVB9,  and mAb IXCI: labeled, in accordance with 
its dual immunofluorescence localization pattern, sarcolem- 
ma, transverse tubule, and triad vesicles (Fig.  10, SL/TS230). 
mAb McB2 to the Na*/K+-ATPase, which is generally con- 
sidered a  surface membrane marker, exhibited labeling of 
triads, transverse tubules and purified sarcolemma (Fig. 10, 
Na/K-ATPase).  Immunofluorescence  labeling  of  skeletal 
muscle cryosections did not show strong enough labeling to 
clarify the localization of this antigen. 
The initial screening of the four subeellular fractions from 
rabbit skeletal muscle established the high degree of purity 
of the sarcolemma preparation used in this study. The prepa- 
ration is essentially free of triads and transverse tubules and 
contains only small amounts of sarcoplasmic reticulum vesi- 
cles, much less than for example the transverse tubule prepa- 
ration. The yield of crude and purified sarcolemma vesicles 
from 450 g of skeletal muscle was ,,o30 and 4 mg protein, 
Figure 7. lmmunoblot analysis  of  crude surface membrane prepara- 
tion. Muscle membranes were prepared as described in Materials 
and Methods and separated by SDS-PAGE followed by immune- 
blotting with mAbs. Shown are a Coomassie blue-stained gel and 
identical immunoblots labeled with mAb IXC12 against SL/TS 
230, mAb XVB9 against SL45, mAb XIXC2 against dystrophin, 
mAb VIA41 against SL156, and mAb IVD31 against SL50. Lanes 
1-4 consist of KCl-washed microsomes, light microsomes, pellet 
from the sucrose-density step gradient and crude surface mem- 
branes from rabbit skeletal muscle (50 #g protein/lane). The mo- 
lecular weight standards (Mr ×  10  -3) are indicated on the left. 
respectively. This makes the WGA agglutination procedure 
described  in this  investigation a  good method to  isolate 
purified sarcolemma vesicles in a sufficiently high yield to 
characterize the components of the dystrophin-glycoprotein 
complex in plasma membrane vesicles. 
Identical immunoblots, which were used for the initial 
Screening of the above characterized subcellular fractions of 
rabbit  skeletal muscle,  were labeled with mAbs  XIXC2, 
VIA4~ and IVD3t against the dystrophin-glycoprotein com- 
plex (Fig. 10). Strong staining of the protein bands for dys- 
trophin, the  156-kD  glycoprotein and 50-kD glycoprotein 
were found in the purified sarcolemma fraction and some 
weak labeling in the transverse tubule fraction. These results 
agree with the immtmofluorescence labeling of the cell pe- 
ripbery with the same mAbs (Fig. 2) and indicate that the 
components  of the  dystrophin-glyeoprotein complex  are 
The Journal of Cell Biology, Volume 112,  1991  144 Figure 8. Flow chart of wheat germ agglutination procedure to isolate purified sarcolemma vesicles. Crude surface membranes were in- 
cubated with WGA and subsequently the agglutinated sareolemma vesicles separated from the WGA void fraction, washed and finally deag- 
glutinated by incubation with N-acetyl-D-glucosamine. Next to the isolated fractions is the lane number in parentheses that will appear 
in the immunoblot analysis of Fig. 9. 
Figure 9. Immunoblot analysis of purified sarcolemma preparation. Shown are a Coomassie blue-stained  gel and identical immunoblots 
labeled with 125I-WGA, polyclonal guinea pig antisera against the ~2-subunit of dihydropyridine receptor (DHPR), mAb IXEll2 against 
TS28, mAb MoB2 against Na+/K+-ATPase, mAb XIXC2 against dystrophin, mAb VIA41 against SL156, mAb IVD3~ against SL50, mAb 
IXCI2 against SLITS 230, and mAb XVB9 against SL45. Lanes 1-3 consist of crude surface membrane, WGA void fraction and purified 
sarcolemma from rabbit skeletal muscle (50 #g protein/lane).  Molecular weight standards (Mr  ×  10  -3) are indicated on the left. 
highly enriched in the purified sarcolemma fraction and are 
probably absent or present only in very low abundance in the 
transverse tubule system. 
Dystrophin Is a Major Component of  Isolated 
Sarcolemma Membranes 
To estimate the amount of dystrophin in the skeletal muscle 
plasma membrane we analyzed purified sarcolemma by den- 
sitometric scanning of Coomassie blue-stained gels. Fig. 11, 
a and b illustrates the Coomassie blue-stained protein band 
pattern of purified rabbit skeletal muscle sareolemma sepa- 
rated by 3-12% SDS-PAGE, and the corresponding immu- 
noblot staining of the dystrophin protein band of apparent 
molecular mass 427 kD using mAb XIXC2. This mAb was 
established  to  be  highly  specific  for  dystrophin  by  im- 
munofluorescence analysis  of normal  control  and  DMD 
muscle samples, as shown in Fig. 5. Peak integration of den- 
sitometric  scans  of isolated  rabbit  skeletal muscle  sarco- 
lemma (Fig. 11 c) revealed that the protein band of apparent 
427 kD accounts for 2.1  +  0.7 (n =  8) % of the total protein 
of this membrane system. To account for possible variations 
in Coomassie blue staining intensity relative to the amount 
of total protein separated by SDS-PAGE, gels with different 
amounts of sarcolemmal protein were analyzed by densito- 
metric scanning and the values averaged. Immunoadsorption 
experiments with XIXC2 immunoaflinity beads quantitative- 
ly remove the 427-kD band from digitonin-solubilized sar- 
colemma (results not shown).  Therefore, the sarcolemmal 
protein band of apparent 427 kD is exclusively dystrophin. 
Our work is the first to demonstrate that dystrophin is a dis- 
crete sarcolemmal protein band in Coomassie blue-stained 
gels and is therefore a major constituent of the skeletal mus- 
cle plasma membrane. 
The  immunoblot  analysis  of WGA-agglutinated  sarco- 
lemma vesicles from rabbit  skeletal  muscle revealed that 
the  dominant  protein  band  of apparent  l l0-kD  contains 
partly the Ca2÷-ATPase of sarcoplasmic reticulum and the 
Na÷/K+-ATPase.  The 210-kD band is myosin according to 
immunoblot staining, using mAb MF20 (results not shown) 
and the 230-kD band corresponds to the SL/TS 230 protein 
newly introduced in this study as a  sarcolemma/transverse 
tubule marker. The dense protein pattern of lower apparent 
Ohlendieck et al. Dystrophin-Glycoprotein Complex in Sarcolemma  145 Figure  10.  Immunoblot analysis of  subcellular 
fractions from rabbit skeletal muscle.  Shown is a 
Coomassie blue-stained gel  and  identical blots 
labeled with  mAb IIHll  against  Ca2+-ATPase, 
mAb XA7 against ryanodine  receptor (RyR), mAb 
I/F7 against the cq-subunit of dihydropyridine  re- 
ceptor (DHPR), mAb XVB9 against SL45, mAb 
XIXC2 against dystrophin,  m.Ab VIA4m against 
SL156, mAb  IVD31 against  SL50, mAb IXC12 
against SLITS 230, and mAb McB2 against Na+/ 
K+-ATPase. Lanes 1-4 consist of light sarcoplas- 
mic reticulum, triads, transverse tubules and sarco- 
lemma from rabbit skeletal muscle (50 ~g protein/ 
lane).  Molecular weight standards  (Mr  x  10  -3) 
are indicated on the left. 
molecular mass bands does not allow a perfect match of im- 
munoblot  labeling  with  mAb  XVB9  against  SL45  and 
IVD3t  against  SL50 and  Coomassie blue-stained protein 
bands.  Actin of 42 kD  is also present in the purified sar- 
colemma,  as detected by immunoblotting with mAb  5C5 
(results not shown). 
Discussion 
This study describes the isolation and characterization of 
sarcolemma membranes from rabbit skeletal muscle using 
mAbs as markers, mAbs against skeletal muscle membrane 
proteins  were  first  characterized  by  immunofluorescence 
labeling of muscle cryosections and then used in the charac- 
terization of purified sarcolemma. The mAbs used in this 
study label antigens with a very specific localization in skele- 
tal muscle cryosections, mAb XVB9 recognizes a sarcolem- 
ma-specific protein of apparent 45 kD and mAb IXC12 la- 
bels a protein of apparent 230 kD, which is localized in the 
sarcolemma and the transverse tubules.  Furthermore,  the 
components of the dystrophin-glycoprotein complex are ex- 
cellent sarcolemma markers as demonstrated by restricted 
sarcolemmal immunofluorescence labeling of their respec- 
tive mAbs. Other marker proteins of various muscle mem- 
branes used in this investigation were characterized previ- 
ously. Whereas the oq and ,2-subunit of the dihydropyridine 
receptor and TS28 protein are localized in the transverse 
tubules system (26, 27) the ryanodine receptor seems to be 
associated with triads (22) and the Ca2+-ATPase is restricted 
to the sarcoplasmic reticulum (24). We used this strategy to 
estimate the purity of our sarcolemma preparation because 
it is advantageous to conventional marker enzyme assays. 
Most estimations of the purity of  plasma membrane prepara- 
tions rely on the use of marker enzyme activity (3, 40, 41). 
However, most surface membrane marker enzymes used are 
not uniquely associated with the sarcolemma, which causes 
problems in the interpretation of marker enzyme activities 
in  subcellular  fractionation studies.  Both Na+/K+-ATPase 
and 5'-nucleotidase, which are widely used as plasma mem- 
brane markers,  are not restricted to the cell periphery in 
skeletal muscle (37). 
Most  skeletal muscle  sarcolemma preparations  employ 
sucrose density gradient centrifugation and plasma  mem- 
brane vesicles appear to be associated with light membrane 
fractions (3, 32, 40, 41). However, our immunoblot analysis 
indicates that crude sarcolemma preparations,  isolated by 
density gradients,  are strongly contaminated with compo- 
nents  of the  sarcoplasmic  reticulum  (results  not  shown). 
Therefore, a specific method for the isolation of sarcolemma 
is needed that relies on the structure and not density of the 
sarcolemma membrane. A wheat germ agglutination proce- 
dure was recently successfully used by Charuk et al. (12) in 
the subfractionation of cardiac sarcolemma and was applied 
in this study in a modified version to circumvent the above- 
mentioned problems in the purification of sarcolemma vesi- 
cles  from rabbit  skeletal  muscle.  The WGA-agglutinated 
vesicle  fraction  appeared  to  be  highly  enriched  in  sar- 
colemma markers and contained only small amounts of sar- 
coplasmic reticulum contaminations, and was essentially free 
of transverse tubules vesicles. Chang et al. fl 1)used ~z~I-WGA 
as a specific plasma membrane marker in fractionation stud- 
ies of  rat tissue and found that WGA was a very suitable label 
of cell surface receptors. The enrichment of a 30-kD protein 
band in purified sarcolemma vesicles agrees with the SDS- 
PAGE analysis of skeletal muscle plasma membrane vesi- 
cles, isolated by the method of Seiler and Fleischer (40). 
Immunoblot analysis of subcelhlar fractions from rabbit 
skeletal muscle demonstrate that components of the dystro- 
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skeletal muscle sarcolemma. Shown is a Coomassie blue-stained 
gel of  purified skeletal muscle sarcolemma (50/~g  protein) (SL) (a), 
an identical immunoblot stained with mAb XIXC2 against dystro- 
phin (Anti-DYS),  (b) and a corresponding densitometric scan of the 
protein band pattern (c). The dystrophin band of apparent 427 kD 
(arrow) made up 2%  of total  rabbit sarcolemma protein and is 
therefore a major component of the purified sarcolemma fraction. 
Molecular weight standards (Mr x  10  -3) are indicated on the left. 
phin-glycoprotein complex are  highly enriched in  sarco- 
lemma vesicles,  mAb  XIXC2,  VIA4t  and IVD3~ against 
dystrophin and its closely associated glycoproteins of appar- 
ent 156 and 50-kD, strongly labeled the purified sarcolemma 
fraction and also stained exclusively the cell periphery of 
transversely and longitudinally  cut muscle cryosections. The 
50-kD glycoprotein was already previously identified as a 
very convenient sarcolemma marker (27).  The finding, that 
dystrophin is associated with the muscle surface membrane, 
agrees with cell fractionation studies of Salviati et al. (38). 
Here we report for the first time in subcellular fractionation 
studies that two dystrophin-associated glycoproteins are re- 
stricted to membrane vesicles which originated from the cell 
periphery. 
Dystrophin  is  an  extremely minor  component of total 
skeletal muscle protein (18). However, our present immuno- 
blot analysis and immunoadsorption data indicate that the 
427-kD protein band of dystrophin accounts for two percent 
of the protein from isolated sarcolemma vesicles. This high 
abundance of dystrophin in the membrane cytoskeleton of 
skeletal muscle cells is comparable to that of  the major mem- 
brane cytoskeleton component spectrin in other cell types 
(10).  An elaborate plasma membrane skeleton is found in 
erythrocytes and spectrin appears to be the major component 
of this membrane skeleton (44).  The predicted amino acid 
sequence of dystrophin indicates a long spectrin-like central 
rod domain of this molecule, which suggests an association 
of dystrophin with the subsarcolemmal cytoskeleton (29). 
Possibly dystrophin is  a  major component of the subsar- 
colemmal cytoskeletal network, which can be an important 
factor for the flexibility and integrity of the surface mem- 
brane during muscle contraction (28). 
Our former finding of a substantial reduction of the SL156 
glycoprotein from muscle of mdx mice and DMD patients 
(15) and the relatively high concentration of dystrophin in 
skeletal muscle sarcolemma reported in this study is analo- 
gous  to  results  in  erythrocytes of patients  afflicted with 
hereditary elliptocytosis (1). Possibly in both diseases, the 
absence of a major cytoskeletal component can lead to the 
disruption of the cytoskeletal network causing fatal desta- 
bilization of the plasma membrane and associated proteins. 
Elevated intracellular Ca  2÷ levels and corresponding higher 
net degradation of muscle proteins in mdx mice (47) may be 
explained by the loss of a dystrophin-associated protein in 
the  sarcolemma,  which  is  involved in  Ca  2÷ homeostasis. 
Dystrophin and its associated glycoproteins may be impor- 
tant factors in linking the cytoskeleton to the extracellular 
matrix, preserving plasma membrane stability, or maintain- 
ing a nonuniform distribution of low abundance glycopro- 
teins, possibly ion channels or cell surface receptors. 
Fast-twitch skeletal muscle fibers are affected earlier in 
muscle from DMD patients than slow-twitch fibers (50). Im- 
munofluorescence localization studies of Schafer and Stock- 
dale  (39)  identified sarcolemma-associated antigens  with 
different distribution in fast and slow skeletal muscle fibers. 
Variability of staining intensity among fibers was also found 
for a sarcolemmal Na÷/K÷-ATPase in chicken muscle (16). 
Therefore, we have examined the fiber-type distribution of 
the  dystrophin-glycoprotein complex.  The  three  compo- 
nents of  the dystrophin-glycoprotein  complex investigated in 
this study are equally distributed between fast- and slow- 
twitch fibers, as illustrated by immunofluorescence labeling 
of serial, transverse cryosections of mixed fiber composition 
with mAbs. It remains to be dete  .rmined why the fiber type 
plays a role in the early steps of abnormal muscle protein 
degradation and fiber necrosis in dystrophic muscle. 
We conclude that the components of the dystrophin-glyco- 
protein complex are highly enriched in the skeletal muscle 
sarcolemma and that dystrophin, which is a minor compo- 
nent of  total muscle protein, is a major constituent of  the sar- 
colemma. Thus, the absence of  dystrophin in DMD may lead 
to instability of the sarcolemma membrane due to its major 
role in the sarcolemma cytoskeleton. This destruction of sar- 
colemmal integrity may be the initial step in the molecular 
pathogenesis of muscular dystrophy. 
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